...
首页> 外文期刊>Microporous and mesoporous materials: The offical journal of the International Zeolite Association >Characterization, in vitro evaluation and comparative study on the cellular internalization of mesoporous silica nanoparticle-supported lipid bilayers
【24h】

Characterization, in vitro evaluation and comparative study on the cellular internalization of mesoporous silica nanoparticle-supported lipid bilayers

机译:介孔二氧化硅纳米粒子纳米粒子脂质双层细胞内化的特征,体外评估和比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

Mesoporous silica nanoparticles (MSNs) and liposomes are inorganic and organic nano-vehicles that are widely used for drug delivery, respectively, however, their application as drug carriers have been limited by some of their inherent defects. In this study, mesoporous silica nanoparticle-supported lipid bilayers (LMSNs) were developed with doxorubicin (DOX) used as the model drug to be loaded. The different nanocarriers, including MSNs, amino-modified MSNs (MSNs-NH2 and MSNs-PEI), as well as LMSNs were systematically characterized and evaluated comparatively in terms of in vitro release, cytotoxicity towards MCF-7 cells, cellular internalization and cellular uptake mechanism. The results indicated that LMSNs had the more effective drug encapsulation, and various nanocarriers exhibited a pH-responsive release feature and the coverage of the lipid bilayer would retard the release of DOX to reach the sustained release effect. Facilitated by the lipid membrane affinity and improved stability supplied by PEGylated lipids, in comparison with both the bare and amino-modified MSNs, the internalization efficiency into cells and cytotoxicity of LMSNs was significantly enhanced. Further study results of the cellular uptake mechanism supported that LMSNs could be internalizated by cells through caveolae mediated endocytosis and macropinocytosis pathway, and these more efficient uptake pathway was probably the important cause for their higher cell internalization and delivery capacity. In summary, the LMSNs were the potent nanocarriers with promising properties and the findings will contribute to the rational design of multifunctional nano-drug carriers for efficient delivery and therapy.
机译:介孔二氧化硅纳米粒子(MSNS)和脂质体是无机的,并且分别广泛用于药物递送的有机纳米载体,然而,它们作为药物载体的应用受到其固有缺陷的一些限制。在该研究中,开发了介孔二氧化硅纳米粒子 - 负载的脂质双层(LMSNS)与用作待装载的模型药物的多柔比星(DOX)开发。不同的纳米载体,包括MSN,氨基修饰的MSN(MSNS-NH2和MSNS-PEI),以及LMSNS在体外释放方面对MCF-7细胞进行细胞毒性,细胞内化和细胞摄取方面的细胞毒性相对较差。机制。结果表明,LMSN具有更有效的药物包封,并且各种纳米载体表现出pH-响应释放特征,并且脂质双层的覆盖率将延迟DOX的释放以达到持续释放效果。通过脂质膜亲和力和通过Pegymated脂质供应的改善的稳定性促进,与裸氨基和氨基修饰的MSN相比,LMSNS的细胞和细胞毒性的内化效率显着提高。进一步研究蜂窝摄取机制的结果支持,LMSN可以通过Caveolae介导的内吞作用和大毒细胞症途径通过细胞内化,并且这些更有效的摄取途径可能是其更高细胞内化和输送能力的重要原因。总之,LMSNS是具有有前途性质的强纳核载体,结果将有助于多官能纳米药物载体的合理设计,以便有效递送和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号